Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02620579 · ClinicalTrials.gov registry record · Phase 2
Biopsychosocial Influence on Shoulder Pain
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 264
- Enrollment target
NCT02620579 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 264 participants.
The verdict
NCT02620579, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 264 participants
- Enrollment target
Study Summary
Chronic shoulder pain is a common, costly, and disabling problem for society. The identification of factors predictive of the development of chronic shoulder pain is necessary to develop innovative and effective treatments to reduce the societal impact of shoulder disorders. In previous work the investigators identified a genetic and psychological subgroup that robustly predicted heightened shoulder pain responses in a pre-clinical cohort and poor 12 month shoulder pain recovery rates in a clinical surgical cohort. In this follow-up study the investigator proposes to test how interventions tailored to the high risk subgroup affect pain responses in a pre-clinical cohort. The optimal theorized match for the identified high-risk subgroup is a combination of personalized pharmaceutical and education interventions. This combined personalized intervention versus a placebo pharmaceutical and general education intervention group is the primary comparison of interest. Also, an evaluation of the individual effect of personalized pharmaceutical and educational interventions will be part of the study. Such comparisons will provide important information on what the active portion of the combined personalized intervention may be.
Interventions
- DRUG Placebo
- DRUG Propranolol LA (60 mg)
- BEHAVIORAL Shoulder Anatomy Education
- BEHAVIORAL Pain Processing Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 264 participants |
| Start Date | 2016-01 |
| Est. Completion | 2021-11-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02620579
The ClinicalTrials.gov registry entry for NCT02620579 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 264 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT02620579 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02620579 about?
NCT02620579 is a clinical study titled "Biopsychosocial Influence on Shoulder Pain". Chronic shoulder pain is a common, costly, and disabling problem for society. The identification of factors predictive of the development of chronic shoulder pain is necessary to develop innovative and effective treatments to reduce the societal impact of shoulder disorders. In previous work the inv...
What is the current status of trial NCT02620579?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 264 participants. The study started on 2016-01. Estimated completion is 2021-11-05.
What interventions are being tested in trial NCT02620579?
The interventions under investigation include: Placebo (DRUG), Propranolol LA (60 mg) (DRUG), Shoulder Anatomy Education (BEHAVIORAL), Pain Processing Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT02620579?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.